Липидный статус у детей и подростков Санкт-Петербурга

N. N. Smirnova; N. B. Kuprienko; S. A.  Urazgildeeva; I. V. Ilienec; T. M. Ivashihina; L. A. Klotchko

doi:10.34687/2219-8202.JAD.2023.02.0003

Authors

N. N. Smirnova Pavlov First Saint Petersburg State Medical University
N. B. Kuprienko Pavlov First Saint Petersburg State Medical University
S. A. Urazgildeeva Scientific, Clinical and Educational Center "Cardiology" of the Faculty of Medicine of St. Petersburg State University
I. V. Ilienec Children's City Multidisciplinary Clinical Center for High Medical Technologies named after K. A. Rauhfus
T. M. Ivashihina St. Petersburg State Budgetary Health Institution "Consulting and Diagnostic Center for Children"
L. A. Klotchko Pavlov First Saint Petersburg State Medical University

DOI:

https://doi.org/10.34687/2219-8202.JAD.2023.02.0003

Keywords:

lipidogram, dyslipidemia, children, trophological status

Abstract

The Objective of the study: to determine the frequency of dyslipidemia (DLP) in various pathological conditions in children and adolescents of St. Petersburg and to identify groups of high risk of early manifestation of atherosclerosis and cardiovascular diseases.

Results: 825 children and adolescents from 2 to 17 years old were examined. There were detected 8 variants of abnormalities in plasma lipid spectrum. The diagnosis of dyslipidemia (DLP) according to two or more deviations from the reference values was established in 122 cases (14.78%). In the group of the highest atherogenic risk are 93 patients (11.3%). Lipidogram data compared with trophological status of patients. Among 122 children with DLP in 50 cases (41.0%), trophological status remained within the age limit; in the group with normal lipidograms, this figure was 20%.

Conclusion: blood lipid spectrum deviations in children are varied; the patients at highest atherogenic risk require thorough examination and genetic analysis; dyslipidemia occurs in children with different trophological status.

Downloads

Download data is not yet available.

Author Biographies

N. N. Smirnova, Pavlov First Saint Petersburg State Medical University

Doctor of Medical Sciences, Professor. Head of the Pediatric Department of the Pavlov University

N. B. Kuprienko, Pavlov First Saint Petersburg State Medical University

PhD, Associate Professor of the Pediatric Department

S. A. Urazgildeeva, Scientific, Clinical and Educational Center "Cardiology" of the Faculty of Medicine of St. Petersburg State University

Doctor of Medical Sciences, Leading Research Fellow, Department of Atherosclerosis of Scientific, Clinical and Educational Center "Cardiology"

I. V. Ilienec, Children's City Multidisciplinary Clinical Center for High Medical Technologies named after K. A. Rauhfus

Deputy chief physician for medical work

T. M. Ivashihina, St. Petersburg State Budgetary Health Institution "Consulting and Diagnostic Center for Children"

Deputy chief physician for medical work

L. A. Klotchko, Pavlov First Saint Petersburg State Medical University

PhD, Associate Professor of the Pediatric Department

References

Don P. Wilson, McNeal C., Blackett P. Pediatric Dyslipidemia: Recommendations for Clinical Management. South Med J. 2015;108(1):7-14. doi: 10.14423/SMJ.0000000000000219.

Kukharchuk V.V., Ezhov M.V., Sergienko I.V., Arabidze G.G., Bubnova M.G., Balakhonova T.V. Diagnosis and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations, VII revision. J Atherosclerosis Dyslididemias 2020;1(38):7-42. Russian. (Кухарчук В.В., Ежов М.В., Сергиенко И.В., Арабидзе Г.Г., Бубнова М.Г., Балахонова Т.В. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации, VII пересмотр. Атеросклероз и дислипидемии. 2020;1(38):7-42). doi: 10.34687/2219-8202.JAD.2020.01.0002

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics. 2011;128 Suppl 5(Suppl 5):213-256. doi: 10.1542/peds.2009-2107C.

Peterkova V.A., Bezlepkina O.B., Bolotova N.V., Bogova E.A., Vasyukova O.V., Girs Y.V. Obesity in children. Clinical guidelines. Problems of Endocrinology. 2021;67(5):67-83. Russian. (Петеркова В.А., Безлепкина О.Б., Болотова Н.В., Богова Е.А., Васюкова О.В., Гирш Я.В. и др. Ожирение у детей. Клинические рекомендации. Проблемы эндокринологии. 2021;67(5):67-83). doi: https://doi.org/10.14341/probl12802.

Сайт Всемирной организации здравоохранения: сердечно-сосудистые заболевания. [Электронный ресурс]. https://www.who.int/tools/growth-reference-data-for-5to19-years/indicators/bmi-for-age (дата обращения: 28.10.2022).

Ezhov M.V., Bazhan S.S., Ershova A.I., Meshkov A.N., Sokolov A.A., Kukharchuk V.V. et al. Clinical guidelines for familial hypercholesterolemia. J Atherosclerosis Dyslididemias. 2020;1(34):5-43. Russian. (Ежов М.В., Бажан С.С., Ежова А.И., Мешков А.В., Соколов А.А., Кухарчук В.В. и др. Клинические рекомендации по семейной гиперхолестеринемии. Атеросклероз и дислипидемии. 2020;1(34):5-43).

Mariko Harada-Shiba M., Takao Ohta, Akira Ohtake Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb.2018;25(6):539-553. doi: 10.5551/jat.CR002.

Lebedev A.V., Malyavskaya S.I., Ternovskaya V.A. Peculiarities of blood lipid range and its disturbances in children and adolescents of Arkhangelsk. Human ecology 2006;6:28-32. Russian. (Лебедев А.В., Малявская С.И., Терновская В.А. Особенности липидного спектра крови и его нарушения у детей и подростков г. Архангельска. Экология человека.2006;6: 28-32).

Maia J.A.F., Pinto F.J.M., Silva F.R., Dantas D.S.G., Sampaio R.M.M., Chaves E.M.C., et al. Prevalence of dyslipidemia in children from 2 to 9 years old. Rev Bras Enferm.2020; 73(Suppl 4): e20190759.doi: http://dx.doi.org/10.1590/0034-7167-2019-0759.

Kuprienko NB, Smirnova NN Prevalence of hypertension in overweight and obese school-age children. Preventive and clinical medicine. 2020; 2(75): 64-69. Russian. (Куприенко Н.Б., Смирнова Н.Н. Распространенность артериальной гипертензии у детей школьного возраста с избыточной массой тела и ожирением. Профилактическая и клиническая медицина. 2020; 2(75):64-69).

Deeb A., Akle M., Al Ozairi A., Cameron F. Common Issues Seen in Pediatric Diabetes Clinics, Psychological Formulations, and Related Approaches to Management. J Diabetes Res. 2018; 2018:1684175. doi: 10.1155/2018/1684175.

Weiss L.A., Pan L., Abney M., Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nature Genetics 2006; 38(2): 218–222. doi: 10.1038/ng1726.

Arnett D.K., Blumenthal R.S., Albert M.A., Buroker A.B., Goldberger Z.D., Hahn E.J. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140(11): 596–646. doi: 10.1161/CIR.0000000000000678.

Wiegman A., Gidding S.S., Watts G.F., Chapman M.J., Ginsberg H.N., Cuchel M. et al. Familial hypercholesterolemia in children and adolescents: gaining decades of life by optimizing detection and treatment// Eur Heart J. 2015; 36(36):2425-2437. doi: 10.1093/eurheartj/ehv157.

Yezhov M.V., Bliznyuk S.A., Tmoyan N.A. Rozhkova T.A., Duplyakov D.V., Salchenko V.A. et al. Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS). Rossiiskii kardiologicheskii zhurnal (Russian Journal of Cardiology). 2019; 5: 7–13. Russian. (Ежов М.В., Близнюк С.А., Тмоян Н.А. Рожкова Т.А., Дупляков Д.В., Сальченко В.А. и др. Регистр пациентов с семейной гиперхолестеринемией и пациентов очень высокого сердечно-сосудистого риска с недостаточной эффективностью проводимой гиполипидемической терапии (РЕНЕССАНС). Российский кардиологический журнал 2019; 5: 7–13). doi: 10.15829/1560-4071-2019-5-7-13.

Sadykova D.I., Shkol’nikova M.A., Galimova L.F., Slastnikova E.C. Statin use in familial hypercholesterolemia in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2020; 65:(5): 139–144. Russian. (Садыкова Д.И., Школьникова М.А., Галимова Л.Ф., Сластникова Е.С. Применение статинов при семейной гиперхолестеринемии у детей. Российский Вестник перинатологии и педиатрии 2020; 65:(5): 139–144). doi: 10.21508/1027–4065–2020–65–5–139–144.

Ference B.A., Yoo W., Alesh I., Mahayan N., Mirowska K.K., Mewada A., et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol. 2012; 60(25): 2631-2639. doi: 10.1016/j.jacc.2012.09.017.

Di Taranto M.D., de Falco R., Guardamagna O., Massini G., Giacobbe C., Auricchio R. et al. Lipid profile and genetic status in a familial hypercholesteroleia pediatric population: exploring the LDL/HDL ratio. Clin Chem Lab Med. 2019; 57(7):1102-1110. doi:10.1515/cclm-2018-1037.